Mycophenolate mofetil in dysimmune neuropathies: A preliminary study

被引：38
|
作者：
Benedetti, L [1 ]
Grandis, M
Nobbio, L
Beronio, A
Ghiglione, E
Manzino, M
Primavera, A
Mancardi, G
Schenone, A
机构：
[1] Univ Genoa, Dept Neurosci Opthalmol & Genet, Genoa, Italy
[2] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy
[3] San Paolo Hosp, Dept Neurol, Savona, Italy
来源：
MUSCLE & NERVE | 2004年 / 29卷 / 05期
关键词：
D O I：
10.1002/mus.20024
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：748 / 749
页数：2
相关论文
共 50 条
  • [41] Treatment of immune-mediated, dysimmune neuropathies
    Finsterer, J
    ACTA NEUROLOGICA SCANDINAVICA, 2005, 112 (02): : 115 - 125
  • [42] SUBCUTANEOUS IMMUNOGLOBULIN IS A SAFE AND EFFECTIVE THERAPY FOR CHRONIC DYSIMMUNE NEUROPATHIES: A NATIONWIDE STUDY
    Cocito, D.
    Merola, A.
    Peci, E.
    Romagnolo, A.
    Lopiano, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 : S9 - S9
  • [43] Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
    Fisse, Anna Lena
    Pitarokoili, Kalliopi
    Gold, Ralf
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (176):
  • [44] Mycophenolate Mofetil in Multiple Sclerosis: A Retrospective Study
    Michel, Laure
    Ongagna, Jean-Claude
    Laplaud, David Axel
    Fleury, Mary
    Blanc, Frederic
    De Seze, Jerome
    Wiertlewski, Sandrine
    NEUROLOGY, 2009, 72 (11) : A361 - A361
  • [45] Preliminary Risk-Benefit Assessment of Mycophenolate Mofetil in Transplant Rejection
    William D. Simmons
    Stephen C. Rayhill
    Hans W. Sollinger
    Drug Safety, 1997, 17 : 75 - 92
  • [46] Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy
    Khadilkar, Satish V.
    Deshmukh, Shrikant S.
    Dhonde, Pramod D.
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2011, 14 (02) : 81 - 92
  • [47] Dysimmune, metabolic and hereditary neuropathies: is ultrasound contributive and how?
    Kerasnoudis, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 14 - 14
  • [48] Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection
    Simmons, WD
    Rayhill, SC
    Sollinger, HW
    DRUG SAFETY, 1997, 17 (02) : 75 - 92
  • [49] Mycophenolate mofetil in dermatology
    Orvis, Alissa K.
    Wesson, Stanton K.
    Breza, Thomas S., Jr.
    Church, Ann A.
    Mitchell, Christina L.
    Watkins, Shannon W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (02) : 183 - 199
  • [50] Mycophenolate mofetil as a teratogen
    Jackson, P. Y.
    Paquette, L.
    Ramanathan, R.
    Seri, I.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 196 - 196
12345